A network meta-analysis of the treatments for esophageal squamous cell carcinoma in terms of survival
Due to its fatal consequences, esophageal cancer is one of the most severe types of cancers (Umar and Fleischer, 2008). With more than 450,000 new cases and 400,000 deaths, it is the eighth most common cancer and the sixth leading cause of death from cancer in the world (Ferlay et al., 2010; Pennathur et al., 2013). Because of its aggressive nature, the prognosis of the disease is poor. Despite improvements in treatment interventions, the five-year survival of the disease is approximately 20 percent (Ferlay et al., 2010; Mao et al., 2011; Shibata et al., 2011).
Source: Critical Reviews in Oncology Hematology - Category: Cancer & Oncology Authors: Amin Doosti-Irani, Kourosh Holakouie-Naieni, Abbas Rahimi-Foroushani, Mohammad Ali Mansournia, Peiman Haddad Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Esophagus Cancer | Hematology | Skin Cancer | Squamous Cell Carcinoma